A clinical trial demonstrated the safety and efficacy of Tresiba (insulin degludec) insulin and showed that it provides a significant reduction in rates of severe hypoglycemia (low blood sugar) in patients with type 2 diabetes when compared to Lantus (insulin glargine). Researchers also found that Tresiba was as safe as Lantus in that it showed no increased risk […].

Insulin Nation hosts a regular Q&A column from IDS that answers questions submitted from the Type 1 diabetes community. Q: Why does a person require basal insulin, even when they are not eating? All questions will be answered, and yours may be chosen to appear in Insulin Nation.

You’re Probably Still Producing Insulin. A study published in Diabetes Care provides more evidence that many people with Type 1 diabetes are still producing a significant amount of insulin, long after becoming dependent on insulin therapy. Better School Diabetes Care.

Some people don’t understand why people with diabetes get upset at the price of insulin. They see insulin for sale at a relatively reasonable price in Walmart and don’t see the problem. What they don’t know is that these Walmart insulins just don’t perform nearly as well as the more expensive insulins, and that gap in performance can have a very negative effect on the health of people with diabetes. These insulins are not interchangeable. Commentary. MORE >>

For many people with Type 1 diabetes, Lantus has been a godsend, a long-acting, slow-release basal insulin that has helped thousands of people achieve better glycemic control. Since Lantus hit the market at the turn of the 21st century, it has also become a goldmine for its parent company, Sanofi, racking up nearly $8 billion in sales in 2013 alone. In fact, the drugmaker raised the price of Lantus twice in 2013. MORE >>

An independent contractor, Clark has had trouble finding affordable health insurance that covers the costs of the insulin she needs to control her Type 1 diabetes. She knows many other people with diabetes that are in the same situation, especially those who use long-acting insulin like Lantus. She says she can’t afford pump therapy and she has cut out all other expenses, including doctor’s visits and dental care, to keep up with the cost of insulin. “We MORE >>

Depending on how tomorrow goes, this could be the last time I completely finish a Lantus pen. Depending on how long it takes to process an order for a new t:slim insulin pump and complete my training, I could be using Humalog as both a basal and bolus insulin. And good riddance, Lantus. Filed under: Wilford Brimley Tagged: Control , Diabetes , insulin pump , Lantus , t:slim. Wilford Brimley Control Diabetes insulin pump Lantus t:slim MORE >>